NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/05/2023
Voltar para busca
Dado oficial do USPTO
STIMVIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
STIMVIA
ST13
US500000090814495Classe
9, 10, 42, 44
Pedido
90814495
Registro
7051655
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
08/07/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 42, 44
Data de depósito
07/07/2021
Data de registro
16/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/05/2023
Última transação
08/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
16
Localização do titular
Ostrava - Hulvaky, CZ
Examinador
MEIER, SHARON A
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Tesla Medical, s.r.o.
Representantes
Cathleen E. Stadecker DOWNS RACHLIN MARTIN PLLC
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Electrodes and devices for neurostimulation for scientific and research purposes; downloadable computer software for use in the design and use of medical instruments and devices used in neuromodulationelectrostimulation or electroceuticals treatment and therapy
Classe 10
Medical electrodes for use in neuromodulationelectrostimulation or electroceuticals therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; medical instruments and devices for use in neuromodulation electrostimulation or electroceuticals treatment and therapy of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility
Classe 42
Design and development of medical instruments and devices for use in neuromodulationelectrostimulation or electroceuticals therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; technology research in the field of medical instruments and devices for use in neuromodulationelectrostimulation or electroceuticals therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; medical and scientific research in the fields of urologyneurologygynecologyoncologyneurodegenerative diseasesoveractive bladderchronic diseases using neuromodulationelectrostimulation or electroceuticals treatment and therapy; providing medical and scientific research information in the fields of urologyneurologygynecologyoncologyneurodegenerative diseases and chronic diseases using electrostimulation or electroceuticals treatment or neuromodulation therapy and treatment; development of technology in the field of medical instruments and devices for neuromodulation therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; design and development of computer software; software as a service (SAAS) services featuring software for use in the design and use of medical instruments and devices used in neuromodulation electrostimulation or electroceuticals treatment therapy and treatment; providing temporary use of on-line non-downloadable software for use in the design and use of medical instruments and devices used in electrostimulationelectroceuticals or neuromodulation treatment and therapy
Classe 44
Medical services in the fields of urologyneurologygynecologyoncologyneurodegenerative diseasesoveractive bladderchronic diseases using electrostimulationelectroceuticals or neuromodulation treatment and therapy; providing medical information in the fields of urologyneurologygynecologyoncologyneurodegenerative diseasesoveractive bladderchronic diseases using electrostimulationelectroceuticals or neuromodulation treatment and therapy; medical treatment and therapy of urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraineinfertilityoveractive bladder and chronic diseases using electrostimulationelectroceuticals or neuromodulation treatment and therapy; rental of medical instruments and devices for use in electrostimulationelectroceuticals or neuromodulation treatment and therapy for urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraineinfertilityoveractive bladder or chronic diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
16/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2023
PUBO
PUBLISHED FOR OPPOSITION
28/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
OTHE
CASE RETURNED TO EXAMINATION
20/01/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
28/12/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
22/12/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
22/12/2022
APET
ASSIGNED TO PETITION STAFF
20/12/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
29/11/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/06/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2022
PUBO
PUBLISHED FOR OPPOSITION
03/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/03/2022
DOCK
ASSIGNED TO EXAMINER
26/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2021
NWAP
NEW APPLICATION ENTERED
10/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STIMVIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.